MT-401 combination therapies (Marker therapeutics)

N/A

Report date: 2025/03/20 16:03:05

Base Information

Drug NameMT-401 combination therapies (Marker therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMarker Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMarker Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A